nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—SLCO1A2—Chlorambucil—testicular cancer	0.403	0.451	CbGbCtD
Fexofenadine—SLCO1B3—Methotrexate—testicular cancer	0.117	0.131	CbGbCtD
Fexofenadine—SLCO1A2—Methotrexate—testicular cancer	0.0722	0.0807	CbGbCtD
Fexofenadine—SLCO1B1—Methotrexate—testicular cancer	0.0681	0.0761	CbGbCtD
Fexofenadine—ABCB1—Dactinomycin—testicular cancer	0.0524	0.0585	CbGbCtD
Fexofenadine—ABCB1—Vinblastine—testicular cancer	0.0328	0.0366	CbGbCtD
Fexofenadine—CYP2D6—Vinblastine—testicular cancer	0.0309	0.0345	CbGbCtD
Fexofenadine—ABCB1—Cisplatin—testicular cancer	0.0301	0.0336	CbGbCtD
Fexofenadine—ABCB1—Etoposide—testicular cancer	0.0295	0.033	CbGbCtD
Fexofenadine—ABCB1—Doxorubicin—testicular cancer	0.0202	0.0225	CbGbCtD
Fexofenadine—ABCB1—Methotrexate—testicular cancer	0.0195	0.0218	CbGbCtD
Fexofenadine—CYP2D6—Doxorubicin—testicular cancer	0.019	0.0212	CbGbCtD
Fexofenadine—Flushing—Bleomycin—testicular cancer	0.000767	0.0073	CcSEcCtD
Fexofenadine—Infection—Chlorambucil—testicular cancer	0.000754	0.00718	CcSEcCtD
Fexofenadine—Otitis media—Doxorubicin—testicular cancer	0.00074	0.00705	CcSEcCtD
Fexofenadine—Abdominal discomfort—Cisplatin—testicular cancer	0.00073	0.00695	CcSEcCtD
Fexofenadine—Flushing—Dactinomycin—testicular cancer	0.000716	0.00681	CcSEcCtD
Fexofenadine—Viral infection—Epirubicin—testicular cancer	0.00069	0.00657	CcSEcCtD
Fexofenadine—Dyspepsia—Chlorambucil—testicular cancer	0.000668	0.00636	CcSEcCtD
Fexofenadine—Flushing—Ifosfamide—testicular cancer	0.000656	0.00624	CcSEcCtD
Fexofenadine—Fatigue—Chlorambucil—testicular cancer	0.000654	0.00623	CcSEcCtD
Fexofenadine—Pain—Chlorambucil—testicular cancer	0.000649	0.00618	CcSEcCtD
Fexofenadine—Viral infection—Doxorubicin—testicular cancer	0.000638	0.00607	CcSEcCtD
Fexofenadine—Cough—Bleomycin—testicular cancer	0.000628	0.00598	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Chlorambucil—testicular cancer	0.000621	0.00591	CcSEcCtD
Fexofenadine—Myalgia—Bleomycin—testicular cancer	0.000613	0.00583	CcSEcCtD
Fexofenadine—Urticaria—Chlorambucil—testicular cancer	0.000603	0.00574	CcSEcCtD
Fexofenadine—Abdominal pain—Chlorambucil—testicular cancer	0.0006	0.00571	CcSEcCtD
Fexofenadine—Body temperature increased—Chlorambucil—testicular cancer	0.0006	0.00571	CcSEcCtD
Fexofenadine—Pain—Vinblastine—testicular cancer	0.000595	0.00566	CcSEcCtD
Fexofenadine—Anaphylactic shock—Bleomycin—testicular cancer	0.000587	0.00559	CcSEcCtD
Fexofenadine—Infection—Bleomycin—testicular cancer	0.000584	0.00556	CcSEcCtD
Fexofenadine—Vision blurred—Ifosfamide—testicular cancer	0.00058	0.00552	CcSEcCtD
Fexofenadine—Dry eye—Epirubicin—testicular cancer	0.000575	0.00548	CcSEcCtD
Fexofenadine—Myalgia—Dactinomycin—testicular cancer	0.000572	0.00544	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Vinblastine—testicular cancer	0.000569	0.00541	CcSEcCtD
Fexofenadine—Flushing—Cisplatin—testicular cancer	0.000565	0.00538	CcSEcCtD
Fexofenadine—Agitation—Ifosfamide—testicular cancer	0.000565	0.00538	CcSEcCtD
Fexofenadine—Angioedema—Ifosfamide—testicular cancer	0.000562	0.00535	CcSEcCtD
Fexofenadine—Hypersensitivity—Chlorambucil—testicular cancer	0.000559	0.00532	CcSEcCtD
Fexofenadine—Abdominal pain—Vinblastine—testicular cancer	0.00055	0.00523	CcSEcCtD
Fexofenadine—Asthenia—Chlorambucil—testicular cancer	0.000545	0.00518	CcSEcCtD
Fexofenadine—Infection—Dactinomycin—testicular cancer	0.000544	0.00518	CcSEcCtD
Fexofenadine—Palpitations—Ifosfamide—testicular cancer	0.000544	0.00517	CcSEcCtD
Fexofenadine—Pruritus—Chlorambucil—testicular cancer	0.000537	0.00511	CcSEcCtD
Fexofenadine—Cough—Ifosfamide—testicular cancer	0.000537	0.00511	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000535	0.00509	CcSEcCtD
Fexofenadine—Dry eye—Doxorubicin—testicular cancer	0.000532	0.00507	CcSEcCtD
Fexofenadine—Dyspnoea—Bleomycin—testicular cancer	0.000524	0.00499	CcSEcCtD
Fexofenadine—Myalgia—Ifosfamide—testicular cancer	0.000524	0.00499	CcSEcCtD
Fexofenadine—Flatulence—Cisplatin—testicular cancer	0.000523	0.00497	CcSEcCtD
Fexofenadine—Diarrhoea—Chlorambucil—testicular cancer	0.000519	0.00494	CcSEcCtD
Fexofenadine—Flushing—Etoposide—testicular cancer	0.000518	0.00493	CcSEcCtD
Fexofenadine—Hypersensitivity—Vinblastine—testicular cancer	0.000512	0.00488	CcSEcCtD
Fexofenadine—Pain—Bleomycin—testicular cancer	0.000502	0.00478	CcSEcCtD
Fexofenadine—Anaphylactic shock—Ifosfamide—testicular cancer	0.000502	0.00478	CcSEcCtD
Fexofenadine—Vision blurred—Cisplatin—testicular cancer	0.0005	0.00476	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000499	0.00475	CcSEcCtD
Fexofenadine—Asthenia—Vinblastine—testicular cancer	0.000499	0.00475	CcSEcCtD
Fexofenadine—Infection—Ifosfamide—testicular cancer	0.000499	0.00475	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Epirubicin—testicular cancer	0.000499	0.00475	CcSEcCtD
Fexofenadine—Vomiting—Chlorambucil—testicular cancer	0.000483	0.00459	CcSEcCtD
Fexofenadine—Increased appetite—Epirubicin—testicular cancer	0.000481	0.00458	CcSEcCtD
Fexofenadine—Diarrhoea—Vinblastine—testicular cancer	0.000476	0.00453	CcSEcCtD
Fexofenadine—Fatigue—Dactinomycin—testicular cancer	0.000472	0.0045	CcSEcCtD
Fexofenadine—Back pain—Etoposide—testicular cancer	0.00047	0.00447	CcSEcCtD
Fexofenadine—Pain—Dactinomycin—testicular cancer	0.000469	0.00446	CcSEcCtD
Fexofenadine—Urticaria—Bleomycin—testicular cancer	0.000467	0.00444	CcSEcCtD
Fexofenadine—Body temperature increased—Bleomycin—testicular cancer	0.000464	0.00442	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Doxorubicin—testicular cancer	0.000461	0.00439	CcSEcCtD
Fexofenadine—Dizziness—Vinblastine—testicular cancer	0.00046	0.00438	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000457	0.00435	CcSEcCtD
Fexofenadine—Pain in extremity—Epirubicin—testicular cancer	0.000452	0.0043	CcSEcCtD
Fexofenadine—Myalgia—Cisplatin—testicular cancer	0.000452	0.0043	CcSEcCtD
Fexofenadine—Nausea—Chlorambucil—testicular cancer	0.000451	0.00429	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000448	0.00426	CcSEcCtD
Fexofenadine—Dyspnoea—Ifosfamide—testicular cancer	0.000448	0.00426	CcSEcCtD
Fexofenadine—Somnolence—Ifosfamide—testicular cancer	0.000446	0.00425	CcSEcCtD
Fexofenadine—Increased appetite—Doxorubicin—testicular cancer	0.000445	0.00424	CcSEcCtD
Fexofenadine—Vomiting—Vinblastine—testicular cancer	0.000442	0.00421	CcSEcCtD
Fexofenadine—Headache—Vinblastine—testicular cancer	0.000436	0.00415	CcSEcCtD
Fexofenadine—Abdominal pain—Dactinomycin—testicular cancer	0.000433	0.00412	CcSEcCtD
Fexofenadine—Body temperature increased—Dactinomycin—testicular cancer	0.000433	0.00412	CcSEcCtD
Fexofenadine—Fatigue—Ifosfamide—testicular cancer	0.000433	0.00412	CcSEcCtD
Fexofenadine—Anaphylactic shock—Cisplatin—testicular cancer	0.000433	0.00412	CcSEcCtD
Fexofenadine—Hypersensitivity—Bleomycin—testicular cancer	0.000433	0.00412	CcSEcCtD
Fexofenadine—Infection—Cisplatin—testicular cancer	0.00043	0.00409	CcSEcCtD
Fexofenadine—Pain—Ifosfamide—testicular cancer	0.000429	0.00409	CcSEcCtD
Fexofenadine—Cough—Etoposide—testicular cancer	0.000424	0.00404	CcSEcCtD
Fexofenadine—Tachycardia—Cisplatin—testicular cancer	0.000422	0.00402	CcSEcCtD
Fexofenadine—Asthenia—Bleomycin—testicular cancer	0.000421	0.00401	CcSEcCtD
Fexofenadine—Pain in extremity—Doxorubicin—testicular cancer	0.000418	0.00398	CcSEcCtD
Fexofenadine—Pruritus—Bleomycin—testicular cancer	0.000416	0.00396	CcSEcCtD
Fexofenadine—Nausea—Vinblastine—testicular cancer	0.000413	0.00393	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000411	0.00391	CcSEcCtD
Fexofenadine—Nasopharyngitis—Epirubicin—testicular cancer	0.000404	0.00385	CcSEcCtD
Fexofenadine—Hypersensitivity—Dactinomycin—testicular cancer	0.000404	0.00384	CcSEcCtD
Fexofenadine—Abdominal discomfort—Methotrexate—testicular cancer	0.0004	0.00381	CcSEcCtD
Fexofenadine—Urticaria—Ifosfamide—testicular cancer	0.000399	0.0038	CcSEcCtD
Fexofenadine—Abdominal pain—Ifosfamide—testicular cancer	0.000397	0.00378	CcSEcCtD
Fexofenadine—Body temperature increased—Ifosfamide—testicular cancer	0.000397	0.00378	CcSEcCtD
Fexofenadine—Anaphylactic shock—Etoposide—testicular cancer	0.000397	0.00377	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000394	0.00375	CcSEcCtD
Fexofenadine—Infection—Etoposide—testicular cancer	0.000394	0.00375	CcSEcCtD
Fexofenadine—Asthenia—Dactinomycin—testicular cancer	0.000393	0.00374	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000388	0.00369	CcSEcCtD
Fexofenadine—Tachycardia—Etoposide—testicular cancer	0.000387	0.00368	CcSEcCtD
Fexofenadine—Dyspnoea—Cisplatin—testicular cancer	0.000386	0.00367	CcSEcCtD
Fexofenadine—Diarrhoea—Dactinomycin—testicular cancer	0.000375	0.00357	CcSEcCtD
Fexofenadine—Nasopharyngitis—Doxorubicin—testicular cancer	0.000374	0.00356	CcSEcCtD
Fexofenadine—Vomiting—Bleomycin—testicular cancer	0.000374	0.00356	CcSEcCtD
Fexofenadine—Drowsiness—Methotrexate—testicular cancer	0.000372	0.00354	CcSEcCtD
Fexofenadine—Rash—Bleomycin—testicular cancer	0.00037	0.00353	CcSEcCtD
Fexofenadine—Pain—Cisplatin—testicular cancer	0.00037	0.00352	CcSEcCtD
Fexofenadine—Dermatitis—Bleomycin—testicular cancer	0.00037	0.00352	CcSEcCtD
Fexofenadine—Hypersensitivity—Ifosfamide—testicular cancer	0.00037	0.00352	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000363	0.00346	CcSEcCtD
Fexofenadine—Pollakiuria—Epirubicin—testicular cancer	0.000361	0.00344	CcSEcCtD
Fexofenadine—Asthenia—Ifosfamide—testicular cancer	0.00036	0.00343	CcSEcCtD
Fexofenadine—Pruritus—Ifosfamide—testicular cancer	0.000355	0.00338	CcSEcCtD
Fexofenadine—Dyspnoea—Etoposide—testicular cancer	0.000354	0.00336	CcSEcCtD
Fexofenadine—Somnolence—Etoposide—testicular cancer	0.000353	0.00336	CcSEcCtD
Fexofenadine—Epistaxis—Methotrexate—testicular cancer	0.000351	0.00334	CcSEcCtD
Fexofenadine—Nausea—Bleomycin—testicular cancer	0.000349	0.00332	CcSEcCtD
Fexofenadine—Drowsiness—Epirubicin—testicular cancer	0.000349	0.00332	CcSEcCtD
Fexofenadine—Vomiting—Dactinomycin—testicular cancer	0.000348	0.00332	CcSEcCtD
Fexofenadine—Rash—Dactinomycin—testicular cancer	0.000345	0.00329	CcSEcCtD
Fexofenadine—Diarrhoea—Ifosfamide—testicular cancer	0.000344	0.00327	CcSEcCtD
Fexofenadine—Body temperature increased—Cisplatin—testicular cancer	0.000342	0.00326	CcSEcCtD
Fexofenadine—Fatigue—Etoposide—testicular cancer	0.000342	0.00325	CcSEcCtD
Fexofenadine—Pain—Etoposide—testicular cancer	0.000339	0.00323	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000336	0.0032	CcSEcCtD
Fexofenadine—Pollakiuria—Doxorubicin—testicular cancer	0.000334	0.00318	CcSEcCtD
Fexofenadine—Dizziness—Ifosfamide—testicular cancer	0.000332	0.00316	CcSEcCtD
Fexofenadine—Epistaxis—Epirubicin—testicular cancer	0.000329	0.00313	CcSEcCtD
Fexofenadine—Sinusitis—Epirubicin—testicular cancer	0.000327	0.00311	CcSEcCtD
Fexofenadine—Nausea—Dactinomycin—testicular cancer	0.000325	0.0031	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Etoposide—testicular cancer	0.000324	0.00309	CcSEcCtD
Fexofenadine—Drowsiness—Doxorubicin—testicular cancer	0.000322	0.00307	CcSEcCtD
Fexofenadine—Vomiting—Ifosfamide—testicular cancer	0.000319	0.00304	CcSEcCtD
Fexofenadine—Hypersensitivity—Cisplatin—testicular cancer	0.000319	0.00304	CcSEcCtD
Fexofenadine—Rash—Ifosfamide—testicular cancer	0.000317	0.00301	CcSEcCtD
Fexofenadine—Dermatitis—Ifosfamide—testicular cancer	0.000316	0.00301	CcSEcCtD
Fexofenadine—Urticaria—Etoposide—testicular cancer	0.000315	0.003	CcSEcCtD
Fexofenadine—Body temperature increased—Etoposide—testicular cancer	0.000313	0.00298	CcSEcCtD
Fexofenadine—Abdominal pain—Etoposide—testicular cancer	0.000313	0.00298	CcSEcCtD
Fexofenadine—Asthenia—Cisplatin—testicular cancer	0.000311	0.00296	CcSEcCtD
Fexofenadine—Epistaxis—Doxorubicin—testicular cancer	0.000304	0.0029	CcSEcCtD
Fexofenadine—Sinusitis—Doxorubicin—testicular cancer	0.000303	0.00288	CcSEcCtD
Fexofenadine—Nausea—Ifosfamide—testicular cancer	0.000298	0.00284	CcSEcCtD
Fexofenadine—Diarrhoea—Cisplatin—testicular cancer	0.000296	0.00282	CcSEcCtD
Fexofenadine—Hypersensitivity—Etoposide—testicular cancer	0.000292	0.00278	CcSEcCtD
Fexofenadine—Flushing—Epirubicin—testicular cancer	0.00029	0.00276	CcSEcCtD
Fexofenadine—Asthenia—Etoposide—testicular cancer	0.000284	0.00271	CcSEcCtD
Fexofenadine—Back pain—Methotrexate—testicular cancer	0.000282	0.00268	CcSEcCtD
Fexofenadine—Pruritus—Etoposide—testicular cancer	0.000281	0.00267	CcSEcCtD
Fexofenadine—Vomiting—Cisplatin—testicular cancer	0.000275	0.00262	CcSEcCtD
Fexofenadine—Vision blurred—Methotrexate—testicular cancer	0.000274	0.00261	CcSEcCtD
Fexofenadine—Rash—Cisplatin—testicular cancer	0.000273	0.0026	CcSEcCtD
Fexofenadine—Dermatitis—Cisplatin—testicular cancer	0.000273	0.0026	CcSEcCtD
Fexofenadine—Diarrhoea—Etoposide—testicular cancer	0.000271	0.00258	CcSEcCtD
Fexofenadine—Flushing—Doxorubicin—testicular cancer	0.000269	0.00256	CcSEcCtD
Fexofenadine—Flatulence—Epirubicin—testicular cancer	0.000268	0.00255	CcSEcCtD
Fexofenadine—Tension—Epirubicin—testicular cancer	0.000267	0.00254	CcSEcCtD
Fexofenadine—Nervousness—Epirubicin—testicular cancer	0.000265	0.00252	CcSEcCtD
Fexofenadine—Back pain—Epirubicin—testicular cancer	0.000263	0.00251	CcSEcCtD
Fexofenadine—Dizziness—Etoposide—testicular cancer	0.000262	0.0025	CcSEcCtD
Fexofenadine—Nausea—Cisplatin—testicular cancer	0.000257	0.00245	CcSEcCtD
Fexofenadine—Vision blurred—Epirubicin—testicular cancer	0.000257	0.00244	CcSEcCtD
Fexofenadine—Cough—Methotrexate—testicular cancer	0.000254	0.00242	CcSEcCtD
Fexofenadine—Vomiting—Etoposide—testicular cancer	0.000252	0.0024	CcSEcCtD
Fexofenadine—Agitation—Epirubicin—testicular cancer	0.00025	0.00238	CcSEcCtD
Fexofenadine—Rash—Etoposide—testicular cancer	0.00025	0.00238	CcSEcCtD
Fexofenadine—Dermatitis—Etoposide—testicular cancer	0.00025	0.00238	CcSEcCtD
Fexofenadine—Headache—Etoposide—testicular cancer	0.000248	0.00236	CcSEcCtD
Fexofenadine—Flatulence—Doxorubicin—testicular cancer	0.000248	0.00236	CcSEcCtD
Fexofenadine—Myalgia—Methotrexate—testicular cancer	0.000248	0.00236	CcSEcCtD
Fexofenadine—Tension—Doxorubicin—testicular cancer	0.000247	0.00235	CcSEcCtD
Fexofenadine—Nervousness—Doxorubicin—testicular cancer	0.000245	0.00233	CcSEcCtD
Fexofenadine—Back pain—Doxorubicin—testicular cancer	0.000244	0.00232	CcSEcCtD
Fexofenadine—Palpitations—Epirubicin—testicular cancer	0.000241	0.00229	CcSEcCtD
Fexofenadine—Cough—Epirubicin—testicular cancer	0.000238	0.00226	CcSEcCtD
Fexofenadine—Anaphylactic shock—Methotrexate—testicular cancer	0.000238	0.00226	CcSEcCtD
Fexofenadine—Vision blurred—Doxorubicin—testicular cancer	0.000237	0.00226	CcSEcCtD
Fexofenadine—Infection—Methotrexate—testicular cancer	0.000236	0.00225	CcSEcCtD
Fexofenadine—Nausea—Etoposide—testicular cancer	0.000236	0.00224	CcSEcCtD
Fexofenadine—Myalgia—Epirubicin—testicular cancer	0.000232	0.00221	CcSEcCtD
Fexofenadine—Agitation—Doxorubicin—testicular cancer	0.000232	0.0022	CcSEcCtD
Fexofenadine—Dry mouth—Epirubicin—testicular cancer	0.000227	0.00216	CcSEcCtD
Fexofenadine—Palpitations—Doxorubicin—testicular cancer	0.000223	0.00212	CcSEcCtD
Fexofenadine—Anaphylactic shock—Epirubicin—testicular cancer	0.000222	0.00212	CcSEcCtD
Fexofenadine—Infection—Epirubicin—testicular cancer	0.000221	0.0021	CcSEcCtD
Fexofenadine—Cough—Doxorubicin—testicular cancer	0.00022	0.00209	CcSEcCtD
Fexofenadine—Tachycardia—Epirubicin—testicular cancer	0.000217	0.00206	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000216	0.00206	CcSEcCtD
Fexofenadine—Insomnia—Methotrexate—testicular cancer	0.000215	0.00204	CcSEcCtD
Fexofenadine—Myalgia—Doxorubicin—testicular cancer	0.000215	0.00204	CcSEcCtD
Fexofenadine—Dyspnoea—Methotrexate—testicular cancer	0.000212	0.00202	CcSEcCtD
Fexofenadine—Somnolence—Methotrexate—testicular cancer	0.000211	0.00201	CcSEcCtD
Fexofenadine—Dry mouth—Doxorubicin—testicular cancer	0.00021	0.002	CcSEcCtD
Fexofenadine—Dyspepsia—Methotrexate—testicular cancer	0.000209	0.00199	CcSEcCtD
Fexofenadine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000206	0.00196	CcSEcCtD
Fexofenadine—Fatigue—Methotrexate—testicular cancer	0.000205	0.00195	CcSEcCtD
Fexofenadine—Infection—Doxorubicin—testicular cancer	0.000204	0.00194	CcSEcCtD
Fexofenadine—Pain—Methotrexate—testicular cancer	0.000203	0.00193	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000203	0.00193	CcSEcCtD
Fexofenadine—Insomnia—Epirubicin—testicular cancer	0.000201	0.00191	CcSEcCtD
Fexofenadine—Tachycardia—Doxorubicin—testicular cancer	0.000201	0.00191	CcSEcCtD
Fexofenadine—Dyspnoea—Epirubicin—testicular cancer	0.000198	0.00189	CcSEcCtD
Fexofenadine—Somnolence—Epirubicin—testicular cancer	0.000198	0.00188	CcSEcCtD
Fexofenadine—Dyspepsia—Epirubicin—testicular cancer	0.000196	0.00186	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000194	0.00185	CcSEcCtD
Fexofenadine—Fatigue—Epirubicin—testicular cancer	0.000192	0.00182	CcSEcCtD
Fexofenadine—Pain—Epirubicin—testicular cancer	0.00019	0.00181	CcSEcCtD
Fexofenadine—Urticaria—Methotrexate—testicular cancer	0.000189	0.0018	CcSEcCtD
Fexofenadine—Abdominal pain—Methotrexate—testicular cancer	0.000188	0.00179	CcSEcCtD
Fexofenadine—Body temperature increased—Methotrexate—testicular cancer	0.000188	0.00179	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000187	0.00178	CcSEcCtD
Fexofenadine—Insomnia—Doxorubicin—testicular cancer	0.000186	0.00177	CcSEcCtD
Fexofenadine—Dyspnoea—Doxorubicin—testicular cancer	0.000183	0.00175	CcSEcCtD
Fexofenadine—Somnolence—Doxorubicin—testicular cancer	0.000183	0.00174	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000182	0.00173	CcSEcCtD
Fexofenadine—Dyspepsia—Doxorubicin—testicular cancer	0.000181	0.00172	CcSEcCtD
Fexofenadine—Fatigue—Doxorubicin—testicular cancer	0.000177	0.00169	CcSEcCtD
Fexofenadine—Urticaria—Epirubicin—testicular cancer	0.000177	0.00168	CcSEcCtD
Fexofenadine—Pain—Doxorubicin—testicular cancer	0.000176	0.00167	CcSEcCtD
Fexofenadine—Body temperature increased—Epirubicin—testicular cancer	0.000176	0.00167	CcSEcCtD
Fexofenadine—Abdominal pain—Epirubicin—testicular cancer	0.000176	0.00167	CcSEcCtD
Fexofenadine—Hypersensitivity—Methotrexate—testicular cancer	0.000175	0.00167	CcSEcCtD
Fexofenadine—Asthenia—Methotrexate—testicular cancer	0.00017	0.00162	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000168	0.0016	CcSEcCtD
Fexofenadine—Pruritus—Methotrexate—testicular cancer	0.000168	0.0016	CcSEcCtD
Fexofenadine—Hypersensitivity—Epirubicin—testicular cancer	0.000164	0.00156	CcSEcCtD
Fexofenadine—Urticaria—Doxorubicin—testicular cancer	0.000163	0.00156	CcSEcCtD
Fexofenadine—Body temperature increased—Doxorubicin—testicular cancer	0.000163	0.00155	CcSEcCtD
Fexofenadine—Abdominal pain—Doxorubicin—testicular cancer	0.000163	0.00155	CcSEcCtD
Fexofenadine—Diarrhoea—Methotrexate—testicular cancer	0.000163	0.00155	CcSEcCtD
Fexofenadine—Asthenia—Epirubicin—testicular cancer	0.000159	0.00152	CcSEcCtD
Fexofenadine—Pruritus—Epirubicin—testicular cancer	0.000157	0.0015	CcSEcCtD
Fexofenadine—Dizziness—Methotrexate—testicular cancer	0.000157	0.0015	CcSEcCtD
Fexofenadine—Diarrhoea—Epirubicin—testicular cancer	0.000152	0.00145	CcSEcCtD
Fexofenadine—Hypersensitivity—Doxorubicin—testicular cancer	0.000152	0.00144	CcSEcCtD
Fexofenadine—Vomiting—Methotrexate—testicular cancer	0.000151	0.00144	CcSEcCtD
Fexofenadine—Rash—Methotrexate—testicular cancer	0.00015	0.00143	CcSEcCtD
Fexofenadine—Dermatitis—Methotrexate—testicular cancer	0.00015	0.00142	CcSEcCtD
Fexofenadine—Headache—Methotrexate—testicular cancer	0.000149	0.00142	CcSEcCtD
Fexofenadine—Asthenia—Doxorubicin—testicular cancer	0.000148	0.0014	CcSEcCtD
Fexofenadine—Dizziness—Epirubicin—testicular cancer	0.000147	0.0014	CcSEcCtD
Fexofenadine—Pruritus—Doxorubicin—testicular cancer	0.000146	0.00139	CcSEcCtD
Fexofenadine—Vomiting—Epirubicin—testicular cancer	0.000141	0.00135	CcSEcCtD
Fexofenadine—Nausea—Methotrexate—testicular cancer	0.000141	0.00134	CcSEcCtD
Fexofenadine—Diarrhoea—Doxorubicin—testicular cancer	0.000141	0.00134	CcSEcCtD
Fexofenadine—Rash—Epirubicin—testicular cancer	0.00014	0.00133	CcSEcCtD
Fexofenadine—Dermatitis—Epirubicin—testicular cancer	0.00014	0.00133	CcSEcCtD
Fexofenadine—Headache—Epirubicin—testicular cancer	0.000139	0.00133	CcSEcCtD
Fexofenadine—Dizziness—Doxorubicin—testicular cancer	0.000136	0.00129	CcSEcCtD
Fexofenadine—Nausea—Epirubicin—testicular cancer	0.000132	0.00126	CcSEcCtD
Fexofenadine—Vomiting—Doxorubicin—testicular cancer	0.000131	0.00124	CcSEcCtD
Fexofenadine—Rash—Doxorubicin—testicular cancer	0.00013	0.00123	CcSEcCtD
Fexofenadine—Dermatitis—Doxorubicin—testicular cancer	0.00013	0.00123	CcSEcCtD
Fexofenadine—Headache—Doxorubicin—testicular cancer	0.000129	0.00123	CcSEcCtD
Fexofenadine—Nausea—Doxorubicin—testicular cancer	0.000122	0.00116	CcSEcCtD
